KYORIN Pharmaceutical Group Facilities Co.,Ltd.

Quality Assurance Initiatives

Quality Policy

We establish a quality policy that prioritizes quality and compliance as our top priority. Additionally, we are seeking to ensure all employees have a thorough understanding through GMP training and posting.

Kyorin Pharmaceutical Group Facilities Co., Ltd.

  • Think of quality first, comply with laws, regulations, and internal standards, and contribute to the medical world by stably supplying high-quality products to our customers.
  • Be a trusted company by listening to the voice of customers and responding to them sincerely.
  • Strive to manufacture even better products at all times through continuous improvement.

Michiro Onota,
President and Representative Director

Quality Policy

KPIs and Quality Objectives

To implement the quality policy, we establish companywide Key Performance Indicators (KPIs) as a commitment of the Kyorin Group. Additionally, we set quality objectives at each manufacturing plant. Our plants are taking several actions to achieve them.

KPIs and Quality Objectives

Assuring Compliance to GMP and Related Laws

Under the guiding principle of “quality first,” each plant periodically provides all employees with GMP training to ensure they have the necessary basic knowledge, including data integrity and appropriate behaviors. Each plant provides periodic training to GMP supervisors based on their position. We also provide new employees with introductory training and E-learning to help them understand the importance of GMP compliance at an early stage.

We proactively ensure consistency between regulatory registration documents and the actual operations of our plants through annual product quality reviews. If any inconsistency is found, we will immediately notify the marketing authorization holder and discuss the next course of action. Also, this fact should be notified to our senior management.

Senior management reviews the control of responsible officers of each plant twice a year in regard to compliance with pharmaceutical laws and regulations.
We establish a quality manual that describes senior management involvement, responsibility, and organization to ensure a pharmaceutical quality system. It also stipulates our compliance system, which is based on the “Guidelines on Compliance of Law for Marketing Authorization Holders and Manufacturers“.

Assuring Compliance to GMP and Related Laws

Data Integrity

To address the potential serious impact on corporate activities, we have developed a data integrity policy that ensures the reliability of GMP data. Additionally, we have established a data integrity standard in accordance with the PIC/S guidance. Each plant creates SOPs based on the standard to guarantee data integrity.

We are utilizing electronic systems such as the production management system and the laboratory information management system to proceed with the digitization of data and records. In addition, we have implemented a QA management system to digitize the workflow of quality systems, including change control, deviation control and document control, in order to prevent any dissipation and falsification of records, as well as avoid overdue tasks.

Data Integrity

Management Review

Senior management reviews the status and actions for KPIs and quality objectives of each plant every month. The improving actions reflect the guidance and advice from management.

Furthermore, the annual management review meeting is held to review and assess the effectiveness of the pharmaceutical quality system, in addition to evaluating the achievement of KPIs and quality objectives. The output from the management review meeting reflects in the resource allocation, quality objectives and action plan for the next fiscal year.